Teleflex Incorporated $TFX Shares Purchased by Walleye Capital LLC

Key Points

• Walleye Capital LLC significantly increased its holdings in Teleflex by 868.6% during the first quarter, owning 64,850 shares valued at approximately $8.96 million.
• Multiple large investors, including Dimensional Fund Advisors and Public Sector Pension Investment Board, also boosted their positions in Teleflex, reflecting strong institutional interest in the company.
• Teleflex announced a $0.34 quarterly dividend to be paid on September 15, and reported better-than-expected earnings of $3.73 EPS, exceeding analyst estimates.

Walleye Capital LLC grew its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 868.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,850 shares of the medical technology company's stock after purchasing an additional 58,155 shares during the quarter. Walleye Capital LLC owned approximately 0.15% of Teleflex worth $8,962,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Teleflex by 30.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company's stock valued at $77,000 after purchasing an additional 129 shares during the period. T. Rowe Price Investment Management Inc. lifted its stake in Teleflex by 0.7% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company's stock worth $859,095,000 after acquiring an additional 43,642 shares during the period. Capital Fund Management S.A. purchased a new stake in Teleflex in the first quarter worth about $7,108,000. Humankind Investments LLC lifted its stake in Teleflex by 11.4% in the first quarter. Humankind Investments LLC now owns 1,586 shares of the medical technology company's stock worth $219,000 after acquiring an additional 162 shares during the period. Finally, Groupama Asset Managment purchased a new stake in Teleflex in the first quarter worth about $250,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Teleflex

In other Teleflex news, Director Gretchen R. Haggerty bought 500 shares of the stock in a transaction on Wednesday, August 6th. The shares were bought at an average price of $114.75 per share, with a total value of $57,375.00. Following the purchase, the director directly owned 6,305 shares in the company, valued at $723,498.75. This trade represents a 8.61% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Stuart A. Randle bought 1,000 shares of the stock in a transaction on Tuesday, August 5th. The shares were acquired at an average cost of $115.86 per share, for a total transaction of $115,860.00. Following the purchase, the director owned 7,547 shares in the company, valued at $874,395.42. The trade was a 15.27% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 5,500 shares of company stock worth $633,590 over the last 90 days. Corporate insiders own 1.40% of the company's stock.

Teleflex Price Performance

Teleflex stock traded up $0.36 during trading on Friday, reaching $126.58. The company had a trading volume of 440,766 shares, compared to its average volume of 553,830. The firm's 50-day simple moving average is $119.05 and its 200 day simple moving average is $128.84. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90. The firm has a market capitalization of $5.59 billion, a PE ratio of 29.78, a price-to-earnings-growth ratio of 1.76 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm had revenue of $780.90 million for the quarter, compared to analysts' expectations of $771.53 million. During the same quarter last year, the company earned $3.42 EPS. The firm's revenue for the quarter was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's payout ratio is 32.00%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Wells Fargo & Company decreased their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Royal Bank Of Canada increased their price target on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. Morgan Stanley decreased their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Wall Street Zen lowered shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Finally, Mizuho increased their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.